These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31535850)

  • 21. Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies.
    Norman BH
    J Med Chem; 2020 Oct; 63(20):11397-11419. PubMed ID: 32511920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network.
    Segovia-Zafra A; Villanueva-Paz M; Serras AS; Matilla-Cabello G; Bodoque-García A; Di Zeo-Sánchez DE; Niu H; Álvarez-Álvarez I; Sanz-Villanueva L; Godec S; Milisav I; Bagnaninchi P; Andrade RJ; Lucena MI; Fernández-Checa JC; Cubero FJ; Miranda JP; Nelson LJ
    J Hepatol; 2024 Oct; 81(4):630-640. PubMed ID: 38703829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward predicting drug-induced liver injury: parallel computational approaches to identify multidrug resistance protein 4 and bile salt export pump inhibitors.
    Welch MA; Köck K; Urban TJ; Brouwer KL; Swaan PW
    Drug Metab Dispos; 2015 May; 43(5):725-34. PubMed ID: 25735837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro Assays.
    Shah F; Leung L; Barton HA; Will Y; Rodrigues AD; Greene N; Aleo MD
    Toxicol Sci; 2015 Oct; 147(2):500-14. PubMed ID: 26206150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
    Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An In Silico Model for Predicting Drug-Induced Hepatotoxicity.
    He S; Ye T; Wang R; Zhang C; Zhang X; Sun G; Sun X
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved Detection of Drug-Induced Liver Injury by Integrating Predicted
    Seal S; Williams DP; Hosseini-Gerami L; Mahale M; Carpenter AE; Spjuth O; Bender A
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a Battery of
    Rathman J; Yang C; Ribeiro JV; Mostrag A; Thakkar S; Tong W; Hobocienski B; Sacher O; Magdziarz T; Bienfait B
    Chem Res Toxicol; 2021 Feb; 34(2):601-615. PubMed ID: 33356149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved Detection of Drug-Induced Liver Injury by Integrating Predicted
    Seal S; Williams D; Hosseini-Gerami L; Mahale M; Carpenter AE; Spjuth O; Bender A
    Chem Res Toxicol; 2024 Aug; 37(8):1290-1305. PubMed ID: 38981058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations.
    Albrecht W; Kappenberg F; Brecklinghaus T; Stoeber R; Marchan R; Zhang M; Ebbert K; Kirschner H; Grinberg M; Leist M; Moritz W; Cadenas C; Ghallab A; Reinders J; Vartak N; van Thriel C; Golka K; Tolosa L; Castell JV; Damm G; Seehofer D; Lampen A; Braeuning A; Buhrke T; Behr AC; Oberemm A; Gu X; Kittana N; van de Water B; Kreiling R; Fayyaz S; van Aerts L; Smedsrød B; Ellinger-Ziegelbauer H; Steger-Hartmann T; Gundert-Remy U; Zeigerer A; Ullrich A; Runge D; Lee SML; Schiergens TS; Kuepfer L; Aguayo-Orozco A; Sachinidis A; Edlund K; Gardner I; Rahnenführer J; Hengstler JG
    Arch Toxicol; 2019 Jun; 93(6):1609-1637. PubMed ID: 31250071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints.
    Liu X; Zheng D; Zhong Y; Xia Z; Luo H; Weng Z
    Biomed Res Int; 2020; 2020():4795140. PubMed ID: 32509859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel MRP3 inhibitors based on computational models and validation using an in vitro membrane vesicle assay.
    Ali I; Welch MA; Lu Y; Swaan PW; Brouwer KLR
    Eur J Pharm Sci; 2017 May; 103():52-59. PubMed ID: 28238947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of DILI Predictive Hypotheses in Early Drug Development.
    Chan R; Benet LZ
    Chem Res Toxicol; 2017 Apr; 30(4):1017-1029. PubMed ID: 28257576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Warner DJ; Chen H; Cantin LD; Kenna JG; Stahl S; Walker CL; Noeske T
    Drug Metab Dispos; 2012 Dec; 40(12):2332-41. PubMed ID: 22961681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Application of a Transcriptomic Signature of Bioactivation in an Advanced In Vitro Liver Model to Reduce Drug-induced Liver Injury Risk Early in the Pharmaceutical Pipeline.
    Kang W; Podtelezhnikov AA; Tanis KQ; Pacchione S; Su M; Bleicher KB; Wang Z; Laws GM; Griffiths TG; Kuhls MC; Chen Q; Knemeyer I; Marsh DJ; Mitra K; Lebron J; Sistare FD
    Toxicol Sci; 2020 Sep; 177(1):121-139. PubMed ID: 32559289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic imaging of adaptive stress response pathway activation for prediction of drug induced liver injury.
    Wink S; Hiemstra SW; Huppelschoten S; Klip JE; van de Water B
    Arch Toxicol; 2018 May; 92(5):1797-1814. PubMed ID: 29502165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current limitations and future opportunities for prediction of DILI from in vitro.
    Funk C; Roth A
    Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model.
    Chen M; Tung CW; Shi Q; Guo L; Shi L; Fang H; Borlak J; Tong W
    Arch Toxicol; 2014 Jul; 88(7):1439-49. PubMed ID: 24958025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals.
    Aleo MD; Shah F; He K; Bonin PD; Rodrigues AD
    Chem Res Toxicol; 2017 May; 30(5):1219-1229. PubMed ID: 28437613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.